← Back to Clinical Trials
Recruiting NCT06310096

NCT06310096 Role of Thoracolumbar Fascia Stretching on Pain Parameters With Non-Specific Chronic Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06310096
Status Recruiting
Phase
Sponsor Atılım University
Condition Pain
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2024-01-01
Primary Completion 2024-08-15

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 60 Years
Study Type INTERVENTIONAL
All Conditions
Interventions
TLF fascial stretching exerciseconventional physiotherapy program.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2024-01-01 with a primary completion date of 2024-08-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Role of Thoracolumbar Fascia Stretching on Pain Parameters with Non-Specific Chronic Low Back Pain

Eligibility Criteria

Inclusion Criteria: * Those who are between the ages of 20-60 and agree to participate in the research, * Those who have lower back pain for at least 3 months, * Individuals who have no perception problems and can cooperate well, * Individuals who attend regular checks and evaluations of the physiotherapy program. Exclusion Criteria: * -Those who have had spinal surgery, * Those who complain of low back pain due to inflammatory, tumoral, metabolic reasons, * Orthopedic obstacles to treatment (pes planus, genu varum, genu valgum, scoliosis, etc.) or Those with neurological problems (Multiple Sclerosis, Stroke, etc.), * Those who have had spine or lower extremity surgery, * Those who have another musculoskeletal disorder affecting the lower extremity, * They are pregnant.

Contact & Investigator

Central Contact

Naime Uluğ, PhD.

✉ naime.ulug@atilim.edu.tr

📞 +90 (312) 586 6110

Principal Investigator

Naime Uluğ, PhD.

PRINCIPAL INVESTIGATOR

ATILIM UNİVERSİTY

Frequently Asked Questions

Who can join the NCT06310096 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 60 Years, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06310096 currently recruiting?

Yes, NCT06310096 is actively recruiting participants. Contact the research team at naime.ulug@atilim.edu.tr for enrollment information.

Where is the NCT06310096 trial being conducted?

This trial is being conducted at Ankara, Turkey (Türkiye).

Who is sponsoring the NCT06310096 clinical trial?

NCT06310096 is sponsored by Atılım University. The principal investigator is Naime Uluğ, PhD. at ATILIM UNİVERSİTY. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology